These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. IL-21 Controls ILC3 Cytokine Production and Promotes a Protective Phenotype in a Mouse Model of Colitis. Poholek CH; Dulson SJ; Zajac AJ; Harrington LE Immunohorizons; 2019 Jun; 3(6):194-202. PubMed ID: 31356165 [TBL] [Abstract][Full Text] [Related]
5. Metabolite-Sensing Receptor Ffar2 Regulates Colonic Group 3 Innate Lymphoid Cells and Gut Immunity. Chun E; Lavoie S; Fonseca-Pereira D; Bae S; Michaud M; Hoveyda HR; Fraser GL; Gallini Comeau CA; Glickman JN; Fuller MH; Layden BT; Garrett WS Immunity; 2019 Nov; 51(5):871-884.e6. PubMed ID: 31628054 [TBL] [Abstract][Full Text] [Related]
6. Luteolin alleviates ulcerative colitis by restoring the balance of NCR Xie X; Zhao M; Huang S; Li P; Chen P; Luo X; Wang Q; Pan Z; Li X; Chen J; Chen B; Zhou L Int Immunopharmacol; 2022 Nov; 112():109251. PubMed ID: 36182875 [TBL] [Abstract][Full Text] [Related]
8. Dahuang Mudan decoction repairs intestinal barrier in chronic colitic mice by regulating the function of ILC3. Huang S; Wang X; Xie X; Su Y; Pan Z; Li Y; Liang J; Zhang M; Pan S; Xu B; Li L; Chen J; Luo X; Zhou L J Ethnopharmacol; 2022 Dec; 299():115652. PubMed ID: 36038092 [TBL] [Abstract][Full Text] [Related]
9. Glial-cell-derived neuroregulators control type 3 innate lymphoid cells and gut defence. Ibiza S; García-Cassani B; Ribeiro H; Carvalho T; Almeida L; Marques R; Misic AM; Bartow-McKenney C; Larson DM; Pavan WJ; Eberl G; Grice EA; Veiga-Fernandes H Nature; 2016 Jul; 535(7612):440-443. PubMed ID: 27409807 [TBL] [Abstract][Full Text] [Related]
10. GLP-1 receptor agonists alleviate colonic inflammation by modulating intestinal microbiota and the function of group 3 innate lymphoid cells. Sun H; Shu J; Tang J; Li Y; Qiu J; Ding Z; Xuan B; Chen M; Gan C; Lin J; Qiu J; Sheng H; Wang C Immunology; 2024 Jul; 172(3):451-468. PubMed ID: 38544428 [TBL] [Abstract][Full Text] [Related]
11. Bacterial Sphingolipids Exacerbate Colitis by Inhibiting ILC3-derived IL-22 Production. Bao B; Wang Y; Boudreau P; Song X; Wu M; Chen X; Patik I; Tang Y; Ouahed J; Ringel A; Barends J; Wu C; Balskus E; Thiagarajah J; Liu J; Wessels MR; Lencer WI; Kasper DL; An D; Horwitz BH; Snapper SB Cell Mol Gastroenterol Hepatol; 2024; 18(2):101350. PubMed ID: 38704148 [TBL] [Abstract][Full Text] [Related]
12. Microbiota-Induced TNF-like Ligand 1A Drives Group 3 Innate Lymphoid Cell-Mediated Barrier Protection and Intestinal T Cell Activation during Colitis. Castellanos JG; Woo V; Viladomiu M; Putzel G; Lima S; Diehl GE; Marderstein AR; Gandara J; Perez AR; Withers DR; Targan SR; Shih DQ; Scherl EJ; Longman RS Immunity; 2018 Dec; 49(6):1077-1089.e5. PubMed ID: 30552020 [TBL] [Abstract][Full Text] [Related]
13. ILC3 function as a double-edged sword in inflammatory bowel diseases. Zeng B; Shi S; Ashworth G; Dong C; Liu J; Xing F Cell Death Dis; 2019 Apr; 10(4):315. PubMed ID: 30962426 [TBL] [Abstract][Full Text] [Related]
14. Modulation of Intestinal ILC3 for the Treatment of Type 1 Diabetes. Stojanović I; Saksida T; Miljković Đ; Pejnović N Front Immunol; 2021; 12():653560. PubMed ID: 34149694 [TBL] [Abstract][Full Text] [Related]